应用德尔菲法确定骨质疏松高风险人群评估工具及评价指标

目的运用德尔菲法筛选骨质疏松高风险人群的评估工具和评价指标,为临床骨质疏松高风险人群的辨识提供依据。方法在文献研究基础上,结合专家意见设计调查问卷,对骨质疏松领域专家进行两轮调查,统计分析专家积极系数、意见集中程度和协调程度。结果第一轮发放问卷20份收回20份,第二轮发放30份收回28份,专家积极系数分别为100%和93.33%。结果显示,骨质疏松风险一分钟测试题、中医评估量表和亚洲人骨质疏松症自我筛查工具可作为骨质疏松高风险人群的风险评估初筛工具;双能X线吸收检测法、骨转换指标、血钙血磷3项应作为主要的辅助检查内容;骨密度、中医证候积分、血钙血磷、平衡能力、生活质量评分、骨转换指标、疼痛视觉模拟评分、跌倒次数、骨折发生次数可作为重点的评价指标。结论基于德尔菲法确定了骨质疏松高风险人群的评估工具及评价指标,为骨质疏松高风险人群的筛选评价提供参考。

Application of the Delphi method to determine the evaluation tools and indicators for people on high-risk of osteoporosis

Objective Delphi method was used to screen the evaluation tools and indicators for people at high risk of osteoporosis, so as to provide reference for the clinic. Methods Questionnaires were designed based on literature research and expert opinions. Two rounds of surveys were conducted among experts in the field of osteoporosis. The positive coefficient, concentration degree, and coordination degree of experts were statistically analyzed. Results In the first round, 20 questionnaires were sent out and 20 were returned. Thirty questionnaires were sent out and 28 were returned in the second round. The positive coefficient of experts was 100% and 93.33%, respectively. The results show that the IOF One-minute osteoporosis risk test, traditional Chinese medicine assessment scale, and osteoporosis self-assessment tool for Asians could be used as risk assessment tools for people at high risk of osteoporosis. Dual energy X-ray absorptiometry, bone conversion index, blood calcium, and blood phosphorus should be taken as the main auxiliary examination contents. Bone mineral density, traditional Chinese medicine syndrome score, blood calcium and phosphorus, balance ability, quality of life score, bone turnover index, pain visual analogue scale, fall times, and fracture occurrence times could be used as key outcome indicators. Conclusion Based on the Delphi method, this study determines the evaluation tools and indicators for people at high-risk of osteoporosis, providing a reference for the screening and evaluation of high-risk population of osteoporosis.